Net income of Amedisys under GAAP for the 3 months of 2022 was $31.713 million, down 36.9% from $50.292 million in the previous year. Revenue increased 1.5% to $545.257 million from $537.144 million a year earlier.

Net income of Amedisys under GAAP for 2021 was $210.166 million, up 13.5% from $185.184 million in the previous year. Revenue increased 6.9% to $2.214 billion from $2.072 billion a year earlier.

Amedisys reported a GAAP net profit of $176.156 million for 9M 2021, up 26.1% from $139.604 million in the previous year. Revenue increased by 8.8% to $1.655 billion from $1.521 billion a year earlier.

Amedisys' GAAP net income for the six months of 2021 was $130.911 million, up 94.8% from $67.193 million in the previous year. Revenues increased 12.8% to $1.101 billion from $0.976 billion a year earlier.